Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
113.70
-0.45 (-0.39%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
July 18, 2024
It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), often referred to as the market’s fear gauge, spiked over 10%, reaching levels...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q2 2024
July 18, 2024
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Abbott Laboratories Q2 Earnings: Revenue And Profit Beat Estimates, Nudges Up Annual Profit Guidance On Strong Medical Devices Growth
July 18, 2024
Abbott Laboratories reported Q2 sales of $10.38 billion, driven by 10.2% growth in Medical Devices, beating EPS estimates with $1.14 per share. Key highlights include FDA approval for two glucose...
Via
Benzinga
Exposures
Product Safety
Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised
July 18, 2024
The drugmaker slightly topped profit and sales forecasts.
Via
Investor's Business Daily
Looking Into Abbott Laboratories's Recent Short Interest
July 10, 2024
Via
Benzinga
7 Analysts Have This To Say About Abbott Laboratories
July 02, 2024
Via
Benzinga
Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens
July 18, 2024
Beaten-down stocks could make a comeback on Thursday, with Taiwan Semiconductor Manufacturing Company Ltd.’s (NYSE:TSM) strong quarterly repo
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
2 Dividend Stocks to Buy and Hold Forever
July 18, 2024
These stocks don't appeal only to dividend seekers.
Via
The Motley Fool
Nasdaq Sees Worst Session Since 2022 As Chip Stocks Tumble After Trump's Taiwan Remarks and Biden's Potential Restrictions
July 18, 2024
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the "Neutral" zone on Wednesday.
Via
Benzinga
Topics
Government
Exposures
Political
D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday
July 18, 2024
Via
Benzinga
Market Whales and Their Recent Bets on ABT Options
June 27, 2024
Via
Benzinga
Abbott Laboratories's Options: A Look at What the Big Money is Thinking
June 10, 2024
Via
Benzinga
Abbott Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
July 18, 2024
Via
Benzinga
Dow Closes At New High As Q2 Earnings Season Heats Up
July 16, 2024
It’s a great start to the trading week. After months of trailing its major-index brethren, the Dow Jones reaches today’s closing bell at a new record high: 40,211. Q2 earnings are coming in well so...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
July 15, 2024
Following a lackluster big bank earnings, market participants now turn their attention to the unfolding week, expecting the trend to reverse.
Via
Benzinga
The 7 Most Undervalued Healthcare Stocks to Buy in July 2024
July 13, 2024
Explore undervalued healthcare stocks offering growth potential and stability in contrast to overvalued tech sector.
Via
InvestorPlace
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
July 10, 2024
These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside.
Via
InvestorPlace
Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits
July 08, 2024
Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
The 3 Best Healthcare Stocks to Buy in July 2024
July 04, 2024
Consistent breakthroughs, improved products and relatively consistent growth make these the best healthcare stocks to buy.
Via
InvestorPlace
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
July 02, 2024
These Dividend Aristocrats all have payouts yielding three times or more the average yield of the S&P 500.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
3 MedTech Stocks to Buy for Healthy Gains
July 01, 2024
With innovations in healthcare moving at a rapid clip, investors should consider these enticing MedTech stocks to buy.
Via
InvestorPlace
Stocks Going Ex Dividend In July 2024
June 27, 2024
This article features a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as...
Via
Talk Markets
Hot Summer Dividends: 3 Sizzling Stocks to Buy for Reliable Income
June 24, 2024
Buying dividend stocks for income is a smart investment strategy to juice your portfolio's returns even in down markets.
Via
InvestorPlace
Top Analyst Reports For Abbott, BP & Gilead
June 21, 2024
Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories, BP p.l.c.and Gilead Sciences, Inc., as well as two micro-cap stocks Smith-Midland Corp. and...
Via
Talk Markets
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
June 20, 2024
The power of compounding can build huge amounts of passive income.
Via
The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
June 20, 2024
These healthcare players offer you dividends and a strong earnings picture.
Via
The Motley Fool
2 Healthcare Stocks to Buy Hand Over Fist in June
June 12, 2024
They both have pretty impressive pasts, and their prospects look just as bright.
Via
The Motley Fool
2 Magnificent Dividend Growth Stocks to Buy Now
June 11, 2024
These two dividend growth stocks are potent capital appreciation vehicles.
Via
The Motley Fool
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
June 10, 2024
The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device.
Via
Investor's Business Daily
Exposures
Product Safety
Class Action Against Abbott's Glucerna Products Proceeds in Federal Court
June 07, 2024
WuXi AppTec employees collaborated with China's PLA on altitude sickness drugs, raising national security concerns in the U.S. Congressional committee calls for restricting biotech ties amid ongoing...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.